Truist lowered the firm’s price target on MasTec (MTZ) to $154 from $197 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in Machinery, Infrastructure Services, and Multi-Industry sector. With continued uncertainty looming around tariffs, the firm sees tempered demand as a short term risk, reflecting prior uncertainty around lack of news around tariffs and now a potential worse-than-expected outcome that is starting to show up in real time data as March ISM manufacturing PMI disappointed while new orders fell short of Street expectations again, the analyst tells investors in a research note. Truist adds that it sees risk that companies will imply demand deteriorated through the first quarter and potentially into April, creating concerns around recession and/or a short term pause in demand, also noting a greater risk to pruning full year guidance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTZ:
- Piper Sandler starts MasTec with an Overweight, $134 price target
- MasTec initiated with an Overweight at Piper Sandler
- MasTec VP of Investor Relations J. Marc Lewis retires, Chris Mecray to succeed
- Okta initiated, Wingstop upgraded: Wall Street’s top analyst calls
- MasTec’s Market Position and Financial Outlook Justify Hold Rating Amid Mixed Performance and Strategic Initiatives